valganciclovir 450 mg tablet - Uses, Side Effects, and More
VOLANE SOURCE 450 is a highly effective medication primarily used to treat infections caused by the cytomegalovirus (CMV), particularly in patients who are immunocompromised. Its active ingredient, Valganciclovir, is a powerful antiviral agent that plays a crucial role in inhibiting CMV replication. VOLANE SOURCE 450 is commonly prescribed to individuals who have undergone organ transplants or are living with HIV/AIDS, as they are at a higher risk of CMV infections.
This article will explore the composition, benefits, usage, and key features of VOLANE SOURCE 450 to help you understand its importance in managing CMV infections.
Composition
VOLANE SOURCE 450 contains Valganciclovir Tablet IP 450 mg, which is the main active ingredient responsible for its therapeutic effects. Valganciclovir is an oral prodrug of Ganciclovir, a potent antiviral agent that directly interferes with the replication of CMV by inhibiting viral DNA synthesis.
- Each tablet contains 450 mg of Valganciclovir.
- The tablet is formulated to ensure effective absorption and targeted delivery of the active ingredient to combat CMV.
Key Features and Ingredients
Active Ingredient: Valganciclovir
Valganciclovir is the active pharmaceutical compound that helps fight cytomegalovirus (CMV) infections. It works by disrupting the replication cycle of CMV, thereby preventing the virus from spreading in the body.450 mg Dosage
Each tablet contains 450 mg of Valganciclovir, which provides a therapeutic dose suitable for managing and preventing the reactivation of CMV infections in individuals with weakened immune systems.Tablet Formulation
The tablet is easy to administer and is formulated for oral use. It ensures effective absorption to achieve the desired therapeutic levels in the body, offering a convenient and manageable treatment option for patients.Indication
VOLANE SOURCE 450 is primarily indicated for the treatment and prevention of CMV retinitis in immunocompromised patients, including those with HIV/AIDS or recipients of organ transplants.
Usage
VOLANE SOURCE 450 is typically prescribed by healthcare providers for the following uses:
Prevention of CMV Infection:
It is used to prevent the development of CMV infections in high-risk patients, especially organ transplant recipients and those with compromised immune systems, like HIV/AIDS patients.Treatment of CMV Retinitis:
It is also employed in the management of CMV retinitis, an eye infection that can lead to blindness if left untreated.
Dosage and Administration:
The recommended dose of VOLANE SOURCE 450 depends on the patient\'s condition and medical history. It is generally advised to take the medication with food to enhance absorption. Your healthcare provider will prescribe the appropriate dosage based on your specific needs.
Benefits of VOLANE SOURCE 450
Prevents CMV Infection in Immunocompromised Patients
VOLANE SOURCE 450 helps prevent the onset of CMV infections in patients with weakened immune systems. This is particularly important for those who have undergone organ transplants or are living with HIV/AIDS, as they are more susceptible to these infections.Treats CMV Retinitis Effectively
For patients with CMV retinitis, VOLANE SOURCE 450 can help treat and manage the infection, reducing the risk of complications, such as vision loss. Early intervention with Valganciclovir can significantly improve outcomes for affected individuals.Convenient Oral Tablet
The oral tablet formulation makes it easy for patients to adhere to their prescribed treatment regimen. The 450 mg dosage provides a manageable and effective option for treating and preventing CMV-related complications.Reduces Risk of Viral Resistance
The Valganciclovir in VOLANE SOURCE 450 helps to inhibit viral replication in the body. When used properly, it reduces the likelihood of CMV developing resistance to treatment, ensuring long-term effectiveness.Improves Patient Outcomes
By controlling CMV infections, VOLANE SOURCE 450 improves the overall health and quality of life for individuals with compromised immune systems. This is crucial in preventing severe complications that could lead to long-term disability or even death.
Conclusion
VOLANE SOURCE 450 (Valganciclovir Tablet IP 450 mg) is a critical medication in the fight against cytomegalovirus infections, especially for immunocompromised patients. Its potent antiviral action, coupled with its convenient oral formulation, makes it a valuable option for preventing and treating CMV retinitis and other CMV-related complications. With proper use and adherence to the prescribed regimen, VOLANE SOURCE 450 can significantly enhance the quality of life and health outcomes for those at risk.Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options. The company offers a wide range of healthcare products, catering to various medical needs, from rare disease treatments to essential healthcare products. Sterispharma\'s product range includes solutions for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. Medicines can be conveniently ordered via Our websites—Sterisonline, Sterisindia, and Sterispharma.
For further information
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 8209542042 , 8824175417
